共 324 条
[11]
Miller ZA(2016)Therapy and clinical trials in frontotemporal dementia: past, present, and future J Neurochem 138 211-221
[12]
Santos-Santos MA(2016)The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease Nature 537 50-56
[13]
Wilson SM(2016)An autoradiographic evaluation of AV-1451 Tau PET in dementia Acta Neuropathol Commun 4 58-800
[14]
Agosta F(2015)Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue Ann Neurol 78 787-119
[15]
Perry DC(2016)Tau positron emission tomographic imaging in aging and early Alzheimer disease Ann Neurol 79 110-1567
[16]
Brown JA(2016)Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease Brain 139 1551-2379
[17]
Possin KL(2016)18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers Brain 139 2372-1178
[18]
Datta S(2017)(18)F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome Neurology 89 1170-766
[19]
Trujillo A(2017)Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations Neurology 88 758-634
[20]
Radke A(2017)18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study Ann Neurol 82 622-128